Paul J. Mellett - 27 Nov 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Reporting relationship: Chief Fin. & Admin Officer
Issuer ticker: ENTA
Reported as of: 27 Nov 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Nov 2024, 17:01:49 UTC
Prior SEC filing: 14 Feb 2024
Next SEC filing: 03 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Matthew Kowalsky as attorney-in-fact

Key filing fact

Paul J. Mellett filed Form 4 for ENANTA PHARMACEUTICALS INC (ENTA) on 27 Nov 2024.

Key facts

This page summarizes Paul J. Mellett's Form 4 filing for ENANTA PHARMACEUTICALS INC (ENTA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Nov 2024, 17:01.

Change

Previous filing in this sequence was filed on 14 Feb 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENTA transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +81,000
Change %
Price: $0.000000
Shares after: 81,000
Date: 27 Nov 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 81,000
Exercise price: $8.83
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 27, 2024).

SEC remarks

Exhibit 24 Power of Attorney filed herewith.